Shanghai Kehua Bio-engineering Co (SZSE:002022) Net Income (Continuing Operations) : ¥-292 Mil (TTM As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shanghai Kehua Bio-engineering Co's Net Income (Continuing Operations) for the three months ended in Jun. 2024 was ¥-16 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥-292 Mil.

Shanghai Kehua Bio-engineering Co Net Income (Continuing Operations) Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co Net Income (Continuing Operations) Chart

Shanghai Kehua Bio-engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

273.39

1,142.20

1,353.83

1,732.22

-176.99

Shanghai Kehua Bio-engineering Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-19.37	-29.23	-225.56	-21.68	-15.82

Shanghai Kehua Bio-engineering Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-292 Mil.

Shanghai Kehua Bio-engineering Co (SZSE:002022) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Shanghai Kehua Bio-engineering Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Kehua Bio-engineering Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233

Website

http://www.skhb.com

Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.

Executives

Li Ming	Executives
He Jian Wen	Executives
Ji Yu Ming	Supervisors
Li Ji	Executives
Sha Li Wu	Director
Wang Man	Directors, executives
Tang Wei Guo	Director

Shanghai Kehua Bio-engineering Co Headlines

No Headlines